Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David MacLean

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer PopulationGlenn Heller, Karim Fizazi, Robert McCormack, et al.
Medicine and Science in Sports and Exercise|April 23, 2015
Oxandrolone Augmentation of Resistance Training in Older Women: A Randomized TrialYorgi Mavros, Evelyn O'Neill, Maureen Connerty, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 26, 2005
Dietary protein intake impacts human skeletal muscle protein fractional synthetic rates after endurance exerciseDouglas R Bolster, Matthew A Pikosky, P Courtney Gaine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2014
Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancerRobert Dreicer, David MacLean, Ajit Suri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Effects of an oral growth hormone secretagogue in older adultsHeidi K White, Charles D Petrie, William Landschulz, et al.
The Journal of Clinical Investigation|August 15, 2024
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1Callum Beach, David MacLean, Dominika Majorova, et al.
The Journal of Clinical Investigation|October 12, 2023
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1Callum Beach, David MacLean, Dominika Majorova, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer PopulationGlenn Heller, Karim Fizazi, Robert McCormack, et al.
Medicine and Science in Sports and Exercise|April 23, 2015
Oxandrolone Augmentation of Resistance Training in Older Women: A Randomized TrialYorgi Mavros, Evelyn O'Neill, Maureen Connerty, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 26, 2005
Dietary protein intake impacts human skeletal muscle protein fractional synthetic rates after endurance exerciseDouglas R Bolster, Matthew A Pikosky, P Courtney Gaine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2014
Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancerRobert Dreicer, David MacLean, Ajit Suri, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Effects of an oral growth hormone secretagogue in older adultsHeidi K White, Charles D Petrie, William Landschulz, et al.
The Journal of Clinical Investigation|August 15, 2024
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1Callum Beach, David MacLean, Dominika Majorova, et al.
The Journal of Clinical Investigation|October 12, 2023
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1Callum Beach, David MacLean, Dominika Majorova, et al.
Pageof 2